VACCINES 2015 – Building Pipelines to Serve Unmet Medical Needs And Target Commercial Opportunity
Wednesday, October 28
4:00 pm – 6:00 pm
Anlyan Center at Yale
300 Cedar Street
New Haven, CT 06519
Details and Registration
This Yale & CURE BioHaven event assembles experts from 4 companies to trade business stories and share their thinking about how to position and sell vaccines to ensure commercial success. We will hear about PREVNAR 13 and other infectious disease vaccines coming down the pike, and interesting R&D to create a pipeline of vaccines to target areas such as smoking cessation and allergic asthma.
Host: Susan Froshauer, Ph.D. – President and CEO of CURE
Moderator: Angela Hwang – Regional President US Vaccines at Pfizer
Panelists
Dr. Anne De Groot – Co-Founder & CEO/CSO, EpiVax
Dr. Donald S. Masters – President & CEO, Artifical Cell Technologies
Dr. Manon Cox – President & CEO, Protein Sciences
Dr. Bijan Almassian – Co-Founder & CEO, CaroGen Corporation